Show Summary Details
Page of

The pathophysiology and immunology of axial spondyloarthritis 

The pathophysiology and immunology of axial spondyloarthritis
Chapter:
The pathophysiology and immunology of axial spondyloarthritis
Author(s):

Stefan Siebert

, Sengupta Raj

, and Alexander Tsoukas

DOI:
10.1093/med/9780198755296.003.0005
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 30 March 2020

Ankylosing spondylitis (AS) is a heterogeneous and complex disease. While the exact pathophysiology remains unclear, significant advances have recently been made in the understanding of several implicated processes. The potential role and interplay of genetic susceptibility, biomechanics, the microbiome, and key cytokines in axial spondyloarthritis (axSpA) is described in this chapter, with particular focus on the IL-23/IL-17 pathway.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.